The Pharmaceutical Journal
Vol 269 No 7222 p637
2 November 2002

This article
Reprint
Photocopy

News summary

Related websites
British Journal of Cancer (more)

Thalidomide analogues

Two classes of second generation thalidomide analogues have shown anti-angiogenic activity independently of immunomodulatory effects.

Researchers say that the study provides further evidence of the clinical potential of these compounds as antitumour drugs (British Journal of Cancer 2002;87:1166).